Dr. Tagawa Discusses the Development of Immunotherapy in Urothelial Cancer – OncLive
|
Dr. Tagawa Discusses the Development of Immunotherapy in Urothelial Cancer
OncLive Scott T. Tagawa, MD, MS, assistant professor of Medicine, medical director, Genitourinary Oncology Research Program, assistant attending physician, New York-Presbyterian Hospital, discusses the development of immunotherapy for patients with urothelial … |
